Predictors of HBeAg loss in HBeAg-positive patients with chronic hepatitis B during treatment with tenofovir alafenamide or tenofovir disoproxil fumarate-MedSci.cn

Predictors of HBeAg loss in HBeAg-positive patients with chronic hepatitis B during treatment with tenofovir alafenamide or tenofovir disoproxil fumarate

Flaherty, J; Kim, K; Jackson, A; Myers, R; Subramanian, M; Agarwal, K; Kong, MK; Lee, KS; Balabanska, R; Ma, M; Pan, C; Abdurakhmanov, D; Bae, H

HIV MEDICINE, 2017; 18 ( ): 42

科室
- - 订阅+
  - 更多科室
工具
服务